Jeffrey Bennett, MD
Psychiatry · Springfield, ILNPI 1265410898
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $385 of the $480 with a category attached, or 80.2%. Every reported general payment came from a single manufacturer, Livanova USA, Inc..
Across 4 payments — averaging $119.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$480
Across 347 payments — averaging $1269.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$275K
- Janssen Research & Development, LLC$46K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$41K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$30K
- Teva Pharmaceuticals USA, Inc.$28K
- Alkermes, Inc.$11K
- plus $9K from 1 others
What the payments were for
- Travel & lodging$38580%
- Food & beverage$9520%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 4 | $480 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$316
How this compares
$480 in reported general payments places this provider in the 65th percentile of 1,344 psychiatry providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 38 | $58,614 |
| AristadaAripiprazole Lauroxil | 13 | $42,774 |
| Aripiprazole | 72 | $18,381 |
| Tetrabenazine | 14 | $11,919 |
| Divalproex Sodium | 93 | $8,445 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 69 | $5,019 |
| Ziprasidone Hcl | 50 | $4,327 |
| Quetiapine Fumarate | 130 | $4,081 |
| Lactulose | 70 | $3,949 |
| Paliperidone ErPaliperidone | 12 | $3,676 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 36 | $3,343 |
| Levocarnitine | 19 | $3,341 |
| Olanzapine | 119 | $3,105 |
| Carbamazepine ErCarbamazepine | 26 | $3,102 |
| RitalinMethylphenidate Hcl | 11 | $2,755 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Springfield
- Andrea StonecipherSpringfield$29K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.